文献速递主动脉疾病

E-nside内分支支架治疗复杂腹主动脉及胸腹主动脉瘤的两年结局:INBREED多中心注册分析

Two Year Outcomes following Off the Shelf Inner Branch Endograft Implantation for the Treatment of Complex Abdominal and Thoraco-Abdominal Aortic Aneurysm: Analysis from the Multicentre ItaliaN Branched Registry of E-nside EnDograft (INBREED).
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-08-25

本研究基于INBREED前瞻性多中心注册,报告E-nside内分支支架治疗复杂腹主动脉瘤(cAAA)和胸腹主动脉瘤(TAAA)的两年结局。共纳入206例患者(TAAA 111例,cAAA 95例),795条目标血管成功重建。两年总生存率90.3%,主动脉相关死亡免除率96%,支架不稳定性免除率97.6%,目标血管不稳定性免除率95.9%,再干预免除率98%。结论认为该支架两年结局良好,规划时需关注近端密封区。

要点

  • E-nside支架治疗cAAA/TAAA两年总生存率90.3%,主动脉相关死亡免除率96%。
  • 支架近端密封失败相关不稳定性免除率97.6%,目标血管不稳定性免除率95.9%。
  • 肾动脉一期通畅率96.1%,内漏免除率99.4%;一年瘤囊回缩率26%,稳定率68%。

核心结论

  • E-nside内分支支架治疗cAAA和TAAA两年结局良好,安全有效预防动脉瘤相关死亡并保证低目标血管不稳定性。
  • 规划时应关注近端密封区以防止随访期间支架不稳定性。

研究设计与样本

  • 前瞻性多中心注册研究(INBREED),分析E-nside内分支支架治疗cAAA和TAAA的数据。
  • 共纳入206例患者(TAAA 111例,53.9%;cAAA 95例,46.1%),795条目标血管成功通过内分支重建,28.6%为急诊修复。

主要发现

  • 两年总生存率90.3%(95%CI 87-97%),主动脉相关死亡免除率96%(95%CI 94-100%)。
  • 近端密封失败相关支架不稳定性免除率97.6%(95%CI 95-100%),目标血管不稳定性免除率95.9%(95%CI 93-97%)。
  • 再干预免除率98%(95%CI 96-99%);肾动脉一期通畅率96.1%(95%CI 93-98%),内漏免除率99.4%(95%CI 98-100%)。
  • 一年时26%病例瘤囊回缩,68%保持稳定。

临床怎么用

  • E-nside支架可用于cAAA和TAAA的治疗,两年结果支持其安全性和有效性。
  • 规划时需重点评估近端密封区,以降低随访期间支架不稳定性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to report the two year outcomes obtained with the E-nside endograft (Artivion) for the treatment of complex abdominal aortic aneurysm (cAAA) and thoraco-abdominal aortic aneurysm (TAAA). METHODS: This was a prospective, multicentre study in which data from the multicentre ItaliaN Branched Registry of E-nside EnDograft (INBREED) registry were analysed. Primary endpoints were aortic related death, main endograft instability, and target vessel (TV) instability. Secondary endpoints were any re-intervention, TV related patency and endoleaks, and aneurysm sac dynamics at one year. RESULTS: There were 206 patients (111 TAAAs, 53.9%; 95 cAAAs, 46.1%), accounting for 795 TVs successfully incorporated through an inner branch; 28.6% had an urgent repair. At two years, overall survival was 90.3% (95% confidence interval [CI] 87 - 97%); freedom from aortic related death was 96% (95% CI 94 - 100%), and freedom from endograft instability related to proximal seal failure was 97.6% (95% CI 95 - 100%). Freedom from TV instability was 95.9% (95% CI 93 - 97%) and freedom from re-intervention was 98% (95% CI 96 - 99%). For renal arteries, primary patency was 96.1% (95% CI 93 - 98%) and freedom from endoleak was 99.4% (95% CI 98 - 100%). At one year, 26% of cases had sac regression and 68% remained stable. CONCLUSION: The E-nside endograft demonstrated good two year outcomes for the treatment of cAAA and TAAA. It safely and effectively prevented aneurysm related death and guaranteed low TV instability. During planning, attention should be given to the proximal sealing zone to prevent graft instability during follow up.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Piazza M, Squizzato F, Pratesi G, et al. Two Year Outcomes following Off the Shelf Inner Branch Endograft Implantation for the Treatment of Complex Abdominal and Thoraco-Abdominal Aortic Aneurysm: Analysis from the Multicentre ItaliaN Branched Registry of E-nside EnDograft (INBREED). Eur J Vasc Endovasc Surg. 2025. PMID: 40865870. doi:10.1016/j.ejvs.2025.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。